Amneal Pharmaceuticals, Inc. Class A Common Stock · AMRX.US · Annual · 2025-12-31 · compared with 2024-12-31

Balance scale

Assets on one bar, liabilities stacked with equity on the other. Both use the same scale.

Assets $3.68B − (Liabilities $3.67B + Equity -$70.79M) = $76.76M · out of balance

Composition

Named lines under 3% of the side are folded into Other. Each stack equals its reported total.

High-level mix

At most five slices. Assets use blue. Liabilities use orange and slate. Equity is green.

Change from prior period

Each step is the change in that group. The last bar is the selected period total.

Recent periods

Last eight periods. Cash, receivables, inventory, and PPE are assets. Total debt is orange. Equity is green.

Line detail

Percents use the same slices as the composition charts. The bar shows magnitude within the side.

Side
Group
Amount
% of side
Change
Change %
Assets
Cash
$310.87M
8.5%
$200.32M
181.2%
Assets
Receivables
$939.87M
25.6%
$164.14M
21.2%
Assets
Inventory
$606.30M
16.5%
-$6.15M
-1.0%
Assets
PPE
$550.33M
15.0%
$26.63M
5.1%
Assets
Goodwill & intangibles
$1.16B
31.5%
-$170.85M
-12.8%
Assets
Other
$111.94M
3.0%
-$37.26M
-25.0%
Liabilities + Equity
Accounts payable
$254.67M
7.1%
-$5.17M
-2.0%
Liabilities + Equity
Long-term debt
$2.57B
71.2%
$403.33M
18.7%
Liabilities + Equity
Other liabilities
$852.53M
23.7%
-$271.82M
-24.2%
Liabilities + Equity
Equity
-$70.79M
-2.0%
$38.47M
35.2%